nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—head and neck cancer	0.843	1	CbGaD
Oxaprozin—Gastrointestinal ulcer—Hydroxyurea—head and neck cancer	0.0125	0.0809	CcSEcCtD
Oxaprozin—Distress—Hydroxyurea—head and neck cancer	0.00696	0.0451	CcSEcCtD
Oxaprozin—Emotional distress—Hydroxyurea—head and neck cancer	0.00454	0.0294	CcSEcCtD
Oxaprozin—Emotional distress—Fluorouracil—head and neck cancer	0.00327	0.0212	CcSEcCtD
Oxaprozin—Peptic ulcer—Vinblastine—head and neck cancer	0.00317	0.0205	CcSEcCtD
Oxaprozin—Rectal haemorrhage—Vinblastine—head and neck cancer	0.00235	0.0152	CcSEcCtD
Oxaprozin—Ulcer—Hydroxyurea—head and neck cancer	0.00204	0.0132	CcSEcCtD
Oxaprozin—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00204	0.0132	CcSEcCtD
Oxaprozin—Heartburn—Fluorouracil—head and neck cancer	0.00202	0.0131	CcSEcCtD
Oxaprozin—Deafness—Vinblastine—head and neck cancer	0.00172	0.0111	CcSEcCtD
Oxaprozin—Hepatic failure—Hydroxyurea—head and neck cancer	0.00156	0.0101	CcSEcCtD
Oxaprozin—Renal failure acute—Hydroxyurea—head and neck cancer	0.00152	0.00984	CcSEcCtD
Oxaprozin—Ulcer—Fluorouracil—head and neck cancer	0.00147	0.00952	CcSEcCtD
Oxaprozin—Heartburn—Docetaxel—head and neck cancer	0.00146	0.00944	CcSEcCtD
Oxaprozin—Coma—Fluorouracil—head and neck cancer	0.00127	0.00823	CcSEcCtD
Oxaprozin—Oesophagitis—Fluorouracil—head and neck cancer	0.00127	0.00823	CcSEcCtD
Oxaprozin—Pancytopenia—Vinblastine—head and neck cancer	0.00126	0.00817	CcSEcCtD
Oxaprozin—Sepsis—Fluorouracil—head and neck cancer	0.00121	0.00781	CcSEcCtD
Oxaprozin—Pancreatitis—Hydroxyurea—head and neck cancer	0.00119	0.00769	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00117	0.00756	CcSEcCtD
Oxaprozin—Myocardial infarction—Vinblastine—head and neck cancer	0.00116	0.00752	CcSEcCtD
Oxaprozin—Pancytopenia—Hydroxyurea—head and neck cancer	0.00115	0.00745	CcSEcCtD
Oxaprozin—Photosensitivity—Fluorouracil—head and neck cancer	0.00115	0.00744	CcSEcCtD
Oxaprozin—Dysuria—Hydroxyurea—head and neck cancer	0.00113	0.00734	CcSEcCtD
Oxaprozin—Agranulocytosis—Vinblastine—head and neck cancer	0.00111	0.00716	CcSEcCtD
Oxaprozin—Oliguria—Docetaxel—head and neck cancer	0.00109	0.00705	CcSEcCtD
Oxaprozin—Drowsiness—Hydroxyurea—head and neck cancer	0.00108	0.007	CcSEcCtD
Oxaprozin—Haemoglobin—Vinblastine—head and neck cancer	0.00107	0.00692	CcSEcCtD
Oxaprozin—Haemorrhage—Vinblastine—head and neck cancer	0.00106	0.00689	CcSEcCtD
Oxaprozin—Hearing impaired—Docetaxel—head and neck cancer	0.00105	0.00683	CcSEcCtD
Oxaprozin—Stomatitis—Hydroxyurea—head and neck cancer	0.00105	0.00682	CcSEcCtD
Oxaprozin—Lethargy—Fluorouracil—head and neck cancer	0.00103	0.00667	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00101	0.00654	CcSEcCtD
Oxaprozin—Haemoglobin—Hydroxyurea—head and neck cancer	0.000975	0.00631	CcSEcCtD
Oxaprozin—Haemorrhage—Hydroxyurea—head and neck cancer	0.00097	0.00628	CcSEcCtD
Oxaprozin—Hallucination—Hydroxyurea—head and neck cancer	0.000965	0.00625	CcSEcCtD
Oxaprozin—Alopecia—Vinblastine—head and neck cancer	0.00094	0.00609	CcSEcCtD
Oxaprozin—Oesophagitis—Docetaxel—head and neck cancer	0.000917	0.00594	CcSEcCtD
Oxaprozin—Sepsis—Docetaxel—head and neck cancer	0.000871	0.00564	CcSEcCtD
Oxaprozin—Eosinophilia—Fluorouracil—head and neck cancer	0.000864	0.00559	CcSEcCtD
Oxaprozin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000859	0.00556	CcSEcCtD
Oxaprozin—Alopecia—Hydroxyurea—head and neck cancer	0.000857	0.00555	CcSEcCtD
Oxaprozin—Anaemia—Vinblastine—head and neck cancer	0.000856	0.00554	CcSEcCtD
Oxaprozin—Malaise—Vinblastine—head and neck cancer	0.000835	0.00541	CcSEcCtD
Oxaprozin—Vertigo—Vinblastine—head and neck cancer	0.000832	0.00539	CcSEcCtD
Oxaprozin—Leukopenia—Vinblastine—head and neck cancer	0.000829	0.00537	CcSEcCtD
Oxaprozin—Pancytopenia—Fluorouracil—head and neck cancer	0.000828	0.00537	CcSEcCtD
Oxaprozin—Fenbufen—PTGS2—head and neck cancer	0.000821	0.342	CrCbGaD
Oxaprozin—Deafness—Docetaxel—head and neck cancer	0.000814	0.00527	CcSEcCtD
Oxaprozin—Hepatic failure—Docetaxel—head and neck cancer	0.000811	0.00525	CcSEcCtD
Oxaprozin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000803	0.0052	CcSEcCtD
Oxaprozin—Convulsion—Vinblastine—head and neck cancer	0.000802	0.0052	CcSEcCtD
Oxaprozin—Hypertension—Vinblastine—head and neck cancer	0.000799	0.00518	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000796	0.00516	CcSEcCtD
Oxaprozin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000784	0.00507	CcSEcCtD
Oxaprozin—Pneumonia—Fluorouracil—head and neck cancer	0.000782	0.00507	CcSEcCtD
Oxaprozin—Anaemia—Hydroxyurea—head and neck cancer	0.000781	0.00505	CcSEcCtD
Oxaprozin—Discomfort—Vinblastine—head and neck cancer	0.000779	0.00504	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000767	0.00497	CcSEcCtD
Oxaprozin—Renal impairment—Docetaxel—head and neck cancer	0.000765	0.00496	CcSEcCtD
Oxaprozin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000762	0.00494	CcSEcCtD
Oxaprozin—Malaise—Hydroxyurea—head and neck cancer	0.000762	0.00493	CcSEcCtD
Oxaprozin—Stomatitis—Fluorouracil—head and neck cancer	0.000758	0.00491	CcSEcCtD
Oxaprozin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000756	0.0049	CcSEcCtD
Oxaprozin—Leukopenia—Hydroxyurea—head and neck cancer	0.000756	0.0049	CcSEcCtD
Oxaprozin—Lethargy—Docetaxel—head and neck cancer	0.000743	0.00481	CcSEcCtD
Oxaprozin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00074	0.00479	CcSEcCtD
Oxaprozin—Convulsion—Hydroxyurea—head and neck cancer	0.000732	0.00474	CcSEcCtD
Oxaprozin—Sinusitis—Fluorouracil—head and neck cancer	0.00073	0.00473	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000729	0.00472	CcSEcCtD
Oxaprozin—Agranulocytosis—Fluorouracil—head and neck cancer	0.000726	0.0047	CcSEcCtD
Oxaprozin—Warfarin—CYP1A1—head and neck cancer	0.000721	0.301	CrCbGaD
Oxaprozin—Anorexia—Vinblastine—head and neck cancer	0.00072	0.00467	CcSEcCtD
Oxaprozin—Discomfort—Hydroxyurea—head and neck cancer	0.00071	0.0046	CcSEcCtD
Oxaprozin—Haemoglobin—Fluorouracil—head and neck cancer	0.000702	0.00454	CcSEcCtD
Oxaprozin—Haemorrhage—Fluorouracil—head and neck cancer	0.000698	0.00452	CcSEcCtD
Oxaprozin—Oedema—Hydroxyurea—head and neck cancer	0.000689	0.00446	CcSEcCtD
Oxaprozin—Infection—Hydroxyurea—head and neck cancer	0.000685	0.00443	CcSEcCtD
Oxaprozin—Paraesthesia—Vinblastine—head and neck cancer	0.000679	0.00439	CcSEcCtD
Oxaprozin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000675	0.00437	CcSEcCtD
Oxaprozin—Abdominal pain upper—Docetaxel—head and neck cancer	0.000665	0.00431	CcSEcCtD
Oxaprozin—Anorexia—Hydroxyurea—head and neck cancer	0.000657	0.00425	CcSEcCtD
Oxaprozin—Decreased appetite—Vinblastine—head and neck cancer	0.000657	0.00425	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000656	0.00425	CcSEcCtD
Oxaprozin—Constipation—Vinblastine—head and neck cancer	0.000646	0.00419	CcSEcCtD
Oxaprozin—Arrhythmia—Fluorouracil—head and neck cancer	0.000624	0.00404	CcSEcCtD
Oxaprozin—Feeling abnormal—Vinblastine—head and neck cancer	0.000623	0.00403	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000618	0.004	CcSEcCtD
Oxaprozin—Alopecia—Fluorouracil—head and neck cancer	0.000617	0.004	CcSEcCtD
Oxaprozin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000614	0.00398	CcSEcCtD
Oxaprozin—Somnolence—Hydroxyurea—head and neck cancer	0.000613	0.00397	CcSEcCtD
Oxaprozin—Dyspepsia—Hydroxyurea—head and neck cancer	0.000607	0.00393	CcSEcCtD
Oxaprozin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000599	0.00388	CcSEcCtD
Oxaprozin—Pancytopenia—Docetaxel—head and neck cancer	0.000598	0.00387	CcSEcCtD
Oxaprozin—Abdominal pain—Vinblastine—head and neck cancer	0.000597	0.00387	CcSEcCtD
Oxaprozin—Constipation—Hydroxyurea—head and neck cancer	0.000589	0.00382	CcSEcCtD
Oxaprozin—Vision blurred—Fluorouracil—head and neck cancer	0.000573	0.00371	CcSEcCtD
Oxaprozin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000568	0.00368	CcSEcCtD
Oxaprozin—Pneumonia—Docetaxel—head and neck cancer	0.000565	0.00366	CcSEcCtD
Oxaprozin—Anaemia—Fluorouracil—head and neck cancer	0.000562	0.00364	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000557	0.0036	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000553	0.00358	CcSEcCtD
Oxaprozin—Renal failure—Docetaxel—head and neck cancer	0.000552	0.00357	CcSEcCtD
Oxaprozin—Myocardial infarction—Docetaxel—head and neck cancer	0.00055	0.00356	CcSEcCtD
Oxaprozin—Stomatitis—Docetaxel—head and neck cancer	0.000547	0.00354	CcSEcCtD
Oxaprozin—Jaundice—Docetaxel—head and neck cancer	0.000547	0.00354	CcSEcCtD
Oxaprozin—Conjunctivitis—Docetaxel—head and neck cancer	0.000546	0.00353	CcSEcCtD
Oxaprozin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000545	0.00353	CcSEcCtD
Oxaprozin—Leukopenia—Fluorouracil—head and neck cancer	0.000544	0.00352	CcSEcCtD
Oxaprozin—Asthenia—Vinblastine—head and neck cancer	0.000542	0.00351	CcSEcCtD
Oxaprozin—Convulsion—Fluorouracil—head and neck cancer	0.000527	0.00341	CcSEcCtD
Oxaprozin—Agranulocytosis—Docetaxel—head and neck cancer	0.000524	0.00339	CcSEcCtD
Oxaprozin—Diarrhoea—Vinblastine—head and neck cancer	0.000517	0.00335	CcSEcCtD
Oxaprozin—Discomfort—Fluorouracil—head and neck cancer	0.000511	0.00331	CcSEcCtD
Oxaprozin—Haemoglobin—Docetaxel—head and neck cancer	0.000507	0.00328	CcSEcCtD
Oxaprozin—Haemorrhage—Docetaxel—head and neck cancer	0.000504	0.00326	CcSEcCtD
Oxaprozin—Hepatitis—Docetaxel—head and neck cancer	0.000504	0.00326	CcSEcCtD
Oxaprozin—Confusional state—Fluorouracil—head and neck cancer	0.0005	0.00324	CcSEcCtD
Oxaprozin—Dizziness—Vinblastine—head and neck cancer	0.0005	0.00324	CcSEcCtD
Oxaprozin—Oedema—Fluorouracil—head and neck cancer	0.000496	0.00321	CcSEcCtD
Oxaprozin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000496	0.00321	CcSEcCtD
Oxaprozin—Asthenia—Hydroxyurea—head and neck cancer	0.000495	0.0032	CcSEcCtD
Oxaprozin—Infection—Fluorouracil—head and neck cancer	0.000493	0.00319	CcSEcCtD
Oxaprozin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000486	0.00315	CcSEcCtD
Oxaprozin—Tachycardia—Fluorouracil—head and neck cancer	0.000484	0.00314	CcSEcCtD
Oxaprozin—Vomiting—Vinblastine—head and neck cancer	0.000481	0.00311	CcSEcCtD
Oxaprozin—Erythema multiforme—Docetaxel—head and neck cancer	0.000477	0.00309	CcSEcCtD
Oxaprozin—Headache—Vinblastine—head and neck cancer	0.000473	0.00307	CcSEcCtD
Oxaprozin—Anorexia—Fluorouracil—head and neck cancer	0.000473	0.00306	CcSEcCtD
Oxaprozin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000472	0.00305	CcSEcCtD
Oxaprozin—Phenylbutazone—PTGS2—head and neck cancer	0.000471	0.197	CrCbGaD
Oxaprozin—Hypotension—Fluorouracil—head and neck cancer	0.000464	0.003	CcSEcCtD
Oxaprozin—Dizziness—Hydroxyurea—head and neck cancer	0.000456	0.00295	CcSEcCtD
Oxaprozin—Arrhythmia—Docetaxel—head and neck cancer	0.00045	0.00292	CcSEcCtD
Oxaprozin—Nausea—Vinblastine—head and neck cancer	0.000449	0.00291	CcSEcCtD
Oxaprozin—Insomnia—Fluorouracil—head and neck cancer	0.000449	0.00291	CcSEcCtD
Oxaprozin—Paraesthesia—Fluorouracil—head and neck cancer	0.000445	0.00288	CcSEcCtD
Oxaprozin—Alopecia—Docetaxel—head and neck cancer	0.000445	0.00288	CcSEcCtD
Oxaprozin—Dyspnoea—Fluorouracil—head and neck cancer	0.000442	0.00286	CcSEcCtD
Oxaprozin—Somnolence—Fluorouracil—head and neck cancer	0.000441	0.00286	CcSEcCtD
Oxaprozin—Vomiting—Hydroxyurea—head and neck cancer	0.000438	0.00284	CcSEcCtD
Oxaprozin—Dyspepsia—Fluorouracil—head and neck cancer	0.000437	0.00283	CcSEcCtD
Oxaprozin—Rash—Hydroxyurea—head and neck cancer	0.000435	0.00281	CcSEcCtD
Oxaprozin—Dermatitis—Hydroxyurea—head and neck cancer	0.000434	0.00281	CcSEcCtD
Oxaprozin—Headache—Hydroxyurea—head and neck cancer	0.000432	0.0028	CcSEcCtD
Oxaprozin—Decreased appetite—Fluorouracil—head and neck cancer	0.000431	0.00279	CcSEcCtD
Oxaprozin—Dysgeusia—Docetaxel—head and neck cancer	0.00043	0.00278	CcSEcCtD
Oxaprozin—Nausea—Hydroxyurea—head and neck cancer	0.000409	0.00265	CcSEcCtD
Oxaprozin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000409	0.00265	CcSEcCtD
Oxaprozin—Anaemia—Docetaxel—head and neck cancer	0.000406	0.00263	CcSEcCtD
Oxaprozin—Urticaria—Fluorouracil—head and neck cancer	0.000394	0.00255	CcSEcCtD
Oxaprozin—Syncope—Docetaxel—head and neck cancer	0.000393	0.00255	CcSEcCtD
Oxaprozin—Leukopenia—Docetaxel—head and neck cancer	0.000393	0.00254	CcSEcCtD
Oxaprozin—Body temperature increased—Fluorouracil—head and neck cancer	0.000392	0.00254	CcSEcCtD
Oxaprozin—Palpitations—Docetaxel—head and neck cancer	0.000388	0.00251	CcSEcCtD
Oxaprozin—Loss of consciousness—Docetaxel—head and neck cancer	0.000386	0.0025	CcSEcCtD
Oxaprozin—Flurbiprofen—PTGS2—head and neck cancer	0.000385	0.16	CrCbGaD
Oxaprozin—Convulsion—Docetaxel—head and neck cancer	0.00038	0.00246	CcSEcCtD
Oxaprozin—Hypertension—Docetaxel—head and neck cancer	0.000379	0.00245	CcSEcCtD
Oxaprozin—Dry mouth—Docetaxel—head and neck cancer	0.000365	0.00237	CcSEcCtD
Oxaprozin—Confusional state—Docetaxel—head and neck cancer	0.000361	0.00234	CcSEcCtD
Oxaprozin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000358	0.00232	CcSEcCtD
Oxaprozin—Oedema—Docetaxel—head and neck cancer	0.000358	0.00232	CcSEcCtD
Oxaprozin—Infection—Docetaxel—head and neck cancer	0.000356	0.0023	CcSEcCtD
Oxaprozin—Shock—Docetaxel—head and neck cancer	0.000352	0.00228	CcSEcCtD
Oxaprozin—Pruritus—Fluorouracil—head and neck cancer	0.000351	0.00227	CcSEcCtD
Oxaprozin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000351	0.00227	CcSEcCtD
Oxaprozin—Tachycardia—Docetaxel—head and neck cancer	0.000349	0.00226	CcSEcCtD
Oxaprozin—Anorexia—Docetaxel—head and neck cancer	0.000341	0.00221	CcSEcCtD
Oxaprozin—Diarrhoea—Fluorouracil—head and neck cancer	0.000339	0.0022	CcSEcCtD
Oxaprozin—Hypotension—Docetaxel—head and neck cancer	0.000335	0.00217	CcSEcCtD
Oxaprozin—Dizziness—Fluorouracil—head and neck cancer	0.000328	0.00212	CcSEcCtD
Oxaprozin—Insomnia—Docetaxel—head and neck cancer	0.000324	0.0021	CcSEcCtD
Oxaprozin—Paraesthesia—Docetaxel—head and neck cancer	0.000322	0.00208	CcSEcCtD
Oxaprozin—Dyspnoea—Docetaxel—head and neck cancer	0.000319	0.00207	CcSEcCtD
Oxaprozin—Somnolence—Docetaxel—head and neck cancer	0.000318	0.00206	CcSEcCtD
Oxaprozin—Vomiting—Fluorouracil—head and neck cancer	0.000315	0.00204	CcSEcCtD
Oxaprozin—Dyspepsia—Docetaxel—head and neck cancer	0.000315	0.00204	CcSEcCtD
Oxaprozin—Rash—Fluorouracil—head and neck cancer	0.000313	0.00203	CcSEcCtD
Oxaprozin—Dermatitis—Fluorouracil—head and neck cancer	0.000313	0.00202	CcSEcCtD
Oxaprozin—Decreased appetite—Docetaxel—head and neck cancer	0.000311	0.00202	CcSEcCtD
Oxaprozin—Headache—Fluorouracil—head and neck cancer	0.000311	0.00201	CcSEcCtD
Oxaprozin—Constipation—Docetaxel—head and neck cancer	0.000306	0.00198	CcSEcCtD
Oxaprozin—Feeling abnormal—Docetaxel—head and neck cancer	0.000295	0.00191	CcSEcCtD
Oxaprozin—Nausea—Fluorouracil—head and neck cancer	0.000295	0.00191	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000293	0.0019	CcSEcCtD
Oxaprozin—Abdominal pain—Docetaxel—head and neck cancer	0.000283	0.00183	CcSEcCtD
Oxaprozin—Body temperature increased—Docetaxel—head and neck cancer	0.000283	0.00183	CcSEcCtD
Oxaprozin—Asthenia—Docetaxel—head and neck cancer	0.000257	0.00166	CcSEcCtD
Oxaprozin—Pruritus—Docetaxel—head and neck cancer	0.000253	0.00164	CcSEcCtD
Oxaprozin—Diarrhoea—Docetaxel—head and neck cancer	0.000245	0.00159	CcSEcCtD
Oxaprozin—Dizziness—Docetaxel—head and neck cancer	0.000237	0.00153	CcSEcCtD
Oxaprozin—Vomiting—Docetaxel—head and neck cancer	0.000228	0.00147	CcSEcCtD
Oxaprozin—Rash—Docetaxel—head and neck cancer	0.000226	0.00146	CcSEcCtD
Oxaprozin—Dermatitis—Docetaxel—head and neck cancer	0.000226	0.00146	CcSEcCtD
Oxaprozin—Headache—Docetaxel—head and neck cancer	0.000224	0.00145	CcSEcCtD
Oxaprozin—Nausea—Docetaxel—head and neck cancer	0.000213	0.00138	CcSEcCtD
